CD8A and neoplasm: Conversely, TASL may enhance the ability of immune cells in the “hot” tumors LUAD and SKCM to kill tumor cells by recruiting Th1 cells in LUAD, CD8+ T cells in SKCM, and inducing the conversion of M2 macrophages to M1 macrophages in SKCM.